Table 4 Vaccine serotype coverage of PCV20 and PPV23 against IPD
Age | PCV20 | PPV23 |
|---|---|---|
18–49 years | 75.4% | 79.5% |
50–64 years | 75.4% | 79.5% |
65–74 years | 53.1% | 66.5% |
75–84 years | 53.1% | 66.5% |
85–99 years | 53.1% | 66.5% |
Age | PCV20 | PPV23 |
|---|---|---|
18–49 years | 75.4% | 79.5% |
50–64 years | 75.4% | 79.5% |
65–74 years | 53.1% | 66.5% |
75–84 years | 53.1% | 66.5% |
85–99 years | 53.1% | 66.5% |